Prozone effect of serum IgE levels in a case of plasma cell leukemia

por Talamo, Giampaolo, Castellani, William, Dolloff, Nathan G
Publicado 2010

2028 Discovery and evaluation of FOXP3 dimerization inhibitors

por Thompson, Ravyn, Coleman, Cara, Dolloff, Nathan G.
Publicado 2018

Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents

por Talamo, Giampaolo, Dolloff, Nathan G., Sharma, Kamal, Zhu, Junjia, Malysz, Jozef
Publicado 2012

PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma

por Robinson, Reeder M., Basar, Ashton P., Reyes, Leticia, Duncan, Ravyn M., Li, Hong, Dolloff, Nathan G.
Publicado 2022

Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma

por Mills, Catherine M., Benton, Thomas Z., Piña, Ivett, Francis, Megan J., Reyes, Leticia, Dolloff, Nathan G., Peterson, Yuri K., Woster, Patrick M.
Publicado 2023

Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation

por Benton, Thomas Z., Mills, Catherine M., Turner, Jonathan M., Francis, Megan J., Solomon, Dalan J., Burger, Pieter B., Peterson, Yuri K., Dolloff, Nathan G., Bachmann, André S., Woster, Patrick M.
Publicado 2021

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

por Thompson, Ravyn M., Dytfeld, Dominik, Reyes, Leticia, Robinson, Reeder M., Smith, Brittany, Manevich, Yefim, Jakubowiak, Andrzej, Komarnicki, Mieczyslaw, Przybylowicz-Chalecka, Anna, Szczepaniak, Tomasz, Mitra, Amit K., Van Ness, Brian G., Luczak, Magdalena, Dolloff, Nathan G.
Publicado 2017